Vontobel Holding’s Palisade Bio PALI Stock Holding History

Vontobel Holding’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-45,000	Closed	-$78.8K	–	1528
2026 Q1	$78.8K	Buy	45,000 +25,000	+125%	+$45.5K	﹤0.01%	1161
2025 Q4	$47K	Buy	+20,000	New	+$38.4K	﹤0.01%	1405

Other funds holding PALI

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vontobel Holding's PALI Position: Q2 2026 in Review

Vontobel Holding sold out of Palisade Bio (PALI) in Q2 2026, closing a stake of 45,000 shares — an estimated $78.8K sold.

Vontobel Holding first reported a position in PALI in Q4 2025 and held it in 2 quarters. The position peaked at $78.8K in Q1 2026. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

Vontobel Holding reported no remaining Palisade Bio position as of Q2 2026 after selling out during the quarter.
Vontobel Holding sold 45,000 Palisade Bio shares in Q2 2026, an estimated $78.8K.
Vontobel Holding first reported a position in Palisade Bio in Q4 2025 and held it in 2 quarters.
Vontobel Holding's Palisade Bio position peaked at $78.8K in Q1 2026.
124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.